David S Boyer Selected Research

Endophthalmitis (Ophthalmia)

1/2020	Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
4/2012	Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
11/2006	Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
10/2006	Ranibizumab for neovascular age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David S Boyer Research Topics

Disease

37	Macular Edema 01/2023 - 04/2004
36	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 07/2002
17	Choroidal Neovascularization 05/2021 - 04/2004
13	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2022 - 04/2004
10	Retinal Vein Occlusion 01/2023 - 03/2013
9	Inflammation (Inflammations) 01/2024 - 11/2006
4	Edema (Dropsy) 01/2023 - 01/2014
4	Geographic Atrophy 06/2022 - 05/2017
4	Endophthalmitis (Ophthalmia) 01/2020 - 10/2006
4	Stroke (Strokes) 03/2015 - 11/2006
3	Cataract (Cataracts) 10/2018 - 04/2012
3	Atrophy 10/2016 - 05/2015
2	Choroidal Effusions 03/2024 - 01/2018
2	Retinal Detachment (Retinal Detachments) 10/2020 - 12/2019
2	Low Vision (Subnormal Vision) 12/2019 - 04/2012
2	Retinal Perforations 01/2019 - 05/2015
2	Microaneurysm 01/2017 - 04/2004
2	Myocardial Infarction 04/2012 - 11/2006
1	Bites and Stings (Sting) 10/2022
1	Eye Diseases (Eye Disease) 10/2022
1	Virus Diseases (Viral Diseases) 10/2022
1	Neoplasms (Cancer) 10/2022
1	Confusion (Bewilderment) 01/2022
1	Ischemia 04/2021
1	Hypoxia (Hypoxemia) 04/2021
1	Vision Disorders (Hemeralopia) 04/2021
1	Vascular Diseases (Vascular Disease) 01/2018
1	Amyloid Plaque 08/2017
1	Alzheimer Disease (Alzheimer's Disease) 08/2017
1	Disease Progression 05/2015
1	Pneumonia (Pneumonitis) 03/2015
1	Vitreous Hemorrhage 07/2014
1	Hemorrhage 03/2014
1	Osteoma 03/2014
1	Melanoma (Melanoma, Malignant) 01/2014
1	Retinal Diseases 01/2014
1	Leiomyosarcoma 01/2014
1	Uveitis 10/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2006
1	Retinitis 04/2006
1	Cytomegalovirus Retinitis 04/2006
1	Central Serous Chorioretinopathy 06/2004
1	Epiretinal Membrane (Epiretinal Membranes) 12/2002

Drug/Important Bio-Agent (IBA)

23	afliberceptIBA 01/2023 - 03/2013
21	Ranibizumab (Lucentis)FDA Link 01/2020 - 10/2006
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 10/2006
11	Retinaldehyde (Retinal)IBA 03/2024 - 01/2014
10	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2006
9	Verteporfin (Visudyne)FDA Link 05/2012 - 04/2004
7	Mitochondrial DNA (mtDNA)IBA 10/2022 - 06/2009
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 05/2011
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2012 - 04/2004
4	Complement System Proteins (Complement)IBA 05/2017 - 01/2014
4	Bevacizumab (Avastin)FDA Link 01/2017 - 04/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 07/2009
3	Fluorescein (Funduscein)FDA LinkGeneric 05/2021 - 04/2004
2	Vascular Endothelial Growth FactorsIBA 01/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 07/2002
2	Complement Factor H (Factor H)IBA 06/2022 - 07/2007
2	risuteganibIBA 01/2022 - 01/2021
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2018 - 01/2018
2	Endothelial Growth FactorsIBA 10/2016 - 07/2009
1	Vascular Endothelial Growth Factor CIBA 01/2023
1	Angiopoietin-2IBA 01/2023
1	SteroidsIBA 01/2023
1	InterferonsIBA 10/2022
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 10/2022
1	Small Interfering RNA (siRNA)IBA 10/2022
1	Ophthalmic Solutions (Eye Drops)IBA 10/2022
1	IntegrinsIBA 10/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	Amine Oxidase (Copper-Containing)IBA 04/2021
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2021
1	Complement C3 (C3 Complement)IBA 01/2020
1	pegcetacoplanIBA 01/2020
1	Plasma KallikreinIBA 12/2019
1	Antihypertensive Agents (Antihypertensives)IBA 12/2019
1	Triamcinolone (Aristocort)FDA Link 01/2018
1	LipidsIBA 08/2017
1	CurcuminIBA 08/2017
1	Amyloid (Amyloid Fibrils)IBA 08/2017
1	Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA 03/2015
1	AKB-9778IBA 03/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2009
1	Antisense OligonucleotidesIBA 07/2009
1	Tyrosine (L-Tyrosine)FDA Link 07/2007
1	Histidine (L-Histidine)FDA Link 07/2007
1	Diclofenac (SR 38)FDA LinkGeneric 07/2007
1	Monoclonal AntibodiesIBA 10/2006
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2006

Therapy/Procedure

18	Lasers (Laser) 01/2019 - 04/2004
13	Therapeutics 01/2019 - 04/2005
11	Light Coagulation 10/2018 - 04/2004
8	Injections 04/2021 - 10/2006
8	Vitrectomy 10/2020 - 10/2002
7	Photochemotherapy (Photodynamic Therapy) 05/2012 - 04/2004
4	Intravitreal Injections 06/2022 - 10/2006
1	Drug Therapy (Chemotherapy) 04/2021
1	Traction 05/2015
1	Brachytherapy 01/2014